Steven R. Deitcher

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Paul M. Ridker, Samuel Z. Goldhaber, Ellie Danielson et al. · New England Journal of Medicine · 2003 · 807 citations · Full text

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Steven R. Deitcher, Craig M. Kessler, Geno J. Merli et al. · Clinical and Applied Thrombosis/Hemostasis · 2006 · 392 citations

Active Cancer, Pharmacotherapy, Cancer Patients +17

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Susan O’Brien, Gary J. Schiller, John Lister et al. · Journal of Clinical Oncology · 2012 · 185 citations

Use of a Constitutively Active Hypoxia-Inducible Factor-1α Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients

Sanjay Rajagopalan, Jeffrey W. Olin, Steven R. Deitcher et al. · Circulation · 2007 · 183 citations

Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease

Gordan Srkalović, Marte Grønlie Cameron, Lisa Rybicki et al. · Cancer · 2004 · 170 citations